BioPharm Asia, Inc (fka BFAR)

[optionchain]

Not speaking for anyone other than myself. I agree that it is good for BFAR with no sale. Didn't seem like that sale was in the best interest of the shareholders! There has never been any confirmation that a sale was ever completed especially without any shareholder input. I wouldn't expect the auditor to respond any differently on acquisition/sales as in my opinion, these transactions have never happened. If the transactions completed we would need to have seen an 8-K showing so and that payment was recived on the sale. Now we know the purchase hasn't taken place sop that makes sense on the auditors response concering that part of the transaction.

Still murky waters but at least a bit more info.